期刊文献+

肺腺癌组织中HSP70多肽复合物的分离及纯化 被引量:1

Separation and purification of heat shock protein 70 peptide complex from human lung adenocarcinoma tissue
下载PDF
导出
摘要 目的:探讨肺腺癌组织中HSP70多肽复合物分离及纯化的可行性方案。方法:采用裂解液裂解、超声破碎、ConA-sepharose亲和层析和DEAE阴离子交换层析方法,从肺腺癌组织中分离纯化HSP70蛋白复合物;通过SDS-PAGE电泳、Westernblot检测获得蛋白;运用Bradford法对其进行定量分析。结果:通过该实验方法可以从1g肺癌组织中获取110μg左右的HSP70多肽复合物,其相对分子质量为70000。结论:采用ConA-sepharose亲和层析和DEAE阴离子亲和层析相结合的蛋白纯化法可以获取高纯度的HSP70多肽复合物。 Aim:To explore a method of separating and purifying HSP70 peptide complex from human lung adenocarcinoma.Methods:HSP70 peptide complex was separated and purified from human lung adenocarcinoma tissue by means of cell lysis,ultrasonication,ConA-sepharose column,and DEAE ion-exchange chromatogaraphy.The purified fractions were tested by SDS-PAGE and Western blot.And quantitative analysis was made by Bradford.Results:About 110 μg HSP70 peptide complex was obtained from 1 g lung adenocarcinoma tissue by this experimental method,with relative molecular weight of 70 000.Conclusion:The high purity HSP70 peptide complex could be obtained by ConA-sepharose column and DEAE ion-exchange chromatogaraphy.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2012年第6期753-755,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金资助项目30600490 河南省教育厅科技创新人才支持计划基金资助项目2008HASTIT028 河南省教育厅自然科学研究基金资助项目2008A320018
关键词 肺腺癌 HSP70多肽复合物 蛋白分离纯化 lung adenocarcinoma HSP70 peptide complex protein separation and purification
  • 相关文献

参考文献10

二级参考文献100

共引文献18

同被引文献14

  • 1黄云鹏,林建华,林志雄.整合素α_vβ_3在肿瘤血管生成中的作用[J].中国肿瘤,2007,16(1):35-38. 被引量:19
  • 2Stupack DG, Cheresh D. Integrins and angiogenesis [J]. Curr Top Dev Biol, 2004, 64: 207-38.
  • 3Niu G, Chen X. Why integrin as a primary target for imaging and therapy[J]. Theranostics, 2011, 1: 30-47.
  • 4Wester HJ, Hamacher K, Stticklin G. A comparative study of N.C.A. fluorine-18 labeling of proteins via acylation and photochemical conjugation[J]. Nucl Med Biol, 1996, 23(3): 365-72.
  • 5Liu S, Liu H, Jiang H, et al. One-step radiosynthesis of SF-A1F-NOTA-RGD2 for tumor angiogenesis PET imaging[J]. Eur J Nucl Med Mol Imaging, 2011, 38(9): 1732-41.
  • 6Tateishi U, Oka T, Inoue T. Radiolabeled RGD peptides as integrin alpha(v)beta3-targeted PET tracers [J]. Curr Med Chem, 2012, 19 (20): 3301-9.
  • 7Poethko T, Schottelius M, Thumshim G, et al. Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and oetreotide analogs[J]. J Nucl Med, 2004, 45(5): 892-902.
  • 8Zhang X, Xiong Z, Wu Y, et al. Quantitative PET imaging of tumor integrin alphavbeta3 expression with 'SF-FRGD2 [J]. J Nucl Med, 2006, 47(1): 113-21.
  • 9Wu Z, Li ZB, Cai W, et al. 'SF-labeled mini-PEG spacered RGD dimer (SF-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression[J]. Eur J Nucl Med Mol Imaging, 2007, 34(11): 1823-31.
  • 10Liu Z, Liu S, Wang F, et al. Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers[J]. Eur J Nucl Med Mol Imaging, 2009, 36(8): 1296-307.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部